Table 4 Multivariate analysis of variables associated with overall survival in patients undergoing repeat TACE
| Overall cohort n = 292 | ||||
|---|---|---|---|---|
| Variable | Hazard Ratio | Lower 95% CI | Higher 95% CI | P value |
| Baseline tumour number, 1, 2,3, > 3 | 1.18 | 1.03 | 1.36 | 0.020 |
| Bilirubin post TACE 1 | 1.02 | 1.00 | 1.03 | 0.007 |
| AFP ≥ 200 ng/ml post TACE 1 | 2.13 | 1.34 | 3.40 | 0.001 |
| Decompensation post TACE 2 | 4.50 | 1.86 | 10.89 | 0.001 |
